VK
Vidhan Kedia
About Vidhan Kedia
Data last updated:
Vidhan Kedia is a Director at Abbvie Therapeutics India Private Limited (since 2023) and Director at Abbvie Healthcare India Private Limited (since 2023). The companies operate in Healthcare, Consumer Goods and Energy and Power. The 2 current companies with reported revenue have a combined latest revenue of ₹711 Cr; the largest is Abbvie Therapeutics India Private Limited at ₹533 Cr (FY 2026). Earlier, Vidhan Kedia was a Cfo at Indo Rama Renewables Limited (2014) and Designated Partner at Indo Rama Renewables Vaspeth Llp (from 2013).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jan 2023 | 1994 | ₹533 Cr (FY 2026) | Active | |
| Director | 25 Jan 2023 | 2008 | ₹179 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Cfo | 01 Apr 2014 | 2012 | ₹7.7 Lakh (FY 2015) | Amalgamated | |
| Designated Partner | 03 Dec 2013 | 2013 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vidhan Kedia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajay Gopikisan Piramal | 00028116 | Abbvie Therapeutics India Private Limited | Director |
| Anup Arvind Godbole | 09342708 | Abbvie Therapeutics India Private Limited | Additional Director |
| Hong Liu Shi | 10424175 | Abbvie Therapeutics India Private Limited , Abbvie Healthcare India Private Limited | Director |
| Kesavan Gopinath | 10307250 | Abbvie Therapeutics India Private Limited | Director |
| Perumal Chinnaiah | Abbvie Therapeutics India Private Limited | Company Secretary | |
| Suresh Pattathil | 02748206 | Abbvie Therapeutics India Private Limited , Abbvie Healthcare India Private Limited | Managing Director |
| Swati Ajay Piramal | 00067125 | Abbvie Therapeutics India Private Limited | Director |
| Vivek Valsaraj | 06970246 | Abbvie Therapeutics India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vidhan Kedia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vidhan Kedia
Vidhan Kedia currently holds 2 directorships: Abbvie Therapeutics India Private Limited (Director, since 24 Jan 2023, revenue ₹533 Cr (FY 2026)); Abbvie Healthcare India Private Limited (Director, since 25 Jan 2023, revenue ₹179 Cr (FY 2025)).
Vidhan Kedia was first appointed on 03 Dec 2013 as Designated Partner at Indo Rama Renewables Vaspeth Llp. The most recent appointment on record is 25 Jan 2023 at Abbvie Healthcare India Private Limited.
The 2 current companies of Vidhan Kedia that report revenue have a combined latest revenue of ₹711 Cr: Abbvie Therapeutics India Private Limited ₹533 Cr (FY 2026); Abbvie Healthcare India Private Limited ₹179 Cr (FY 2025).
Vidhan Kedia held 2 earlier board appointments: Indo Rama Renewables Limited (Cfo, 01 Apr 2014 to 26 Sep 2014); Indo Rama Renewables Vaspeth Llp (Designated Partner, from 03 Dec 2013).
The current boards of Vidhan Kedia's companies include Ajay Gopikisan Piramal (Abbvie Therapeutics India Private Limited), Anup Arvind Godbole (Abbvie Therapeutics India Private Limited), Hong Liu Shi (Abbvie Therapeutics India Private Limited), Kesavan Gopinath (Abbvie Therapeutics India Private Limited), Perumal Chinnaiah (Abbvie Therapeutics India Private Limited), Suresh Pattathil (Abbvie Therapeutics India Private Limited), among others.